Similar articles for PMID: 12957508

Year	Number of Results
1986	1
1987	1
1991	1
1994	5
1995	14
1996	27
1997	18
1998	11
1999	10
2000	16
2001	11
2002	19
2003	16
2004	8
2005	7
2006	3
2007	5
2008	7
2009	4
2010	11
2011	9
2012	10
2013	9
2014	14
2015	7
2016	10
2017	10
2018	16
2019	30
2020	34
2021	34
2022	29
2023	19
2024	1

1

APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Fukumoto H, Ingelsson M, Gårevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC. Fukumoto H, et al. Exp Neurol. 2003 Sep;183(1):249-53. doi: 10.1016/s0014-4886(03)00088-8. Exp Neurol. 2003. PMID: 12957508

2

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.

Martínez-Morillo E, Hansson O, Atagi Y, Bu G, Minthon L, Diamandis EP, Nielsen HM. Martínez-Morillo E, et al. Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15. Acta Neuropathol. 2014. PMID: 24633805

3

Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.

Nakamura T, Kawarabayashi T, Ueda T, Shimomura S, Hoshino M, Itoh K, Ihara K, Nakaji S, Takatama M, Ikeda Y, Shoji M. Nakamura T, et al. J Alzheimers Dis. 2023;93(1):333-348. doi: 10.3233/JAD-220996. J Alzheimers Dis. 2023. PMID: 36970894

4

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Lehtimäki T, Pirttilä T, Mehta PD, Wisniewski HM, Frey H, Nikkari T. Lehtimäki T, et al. Hum Genet. 1995 Jan;95(1):39-42. doi: 10.1007/BF00225071. Hum Genet. 1995. PMID: 7814023

5

In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.

Tangwongchai S, Supasitthumrong T, Hemrunroj S, Tunvirachaisakul C, Chuchuen P, Houngngam N, Snabboon T, Tawankanjanachot I, Likitchareon Y, Phanthumchindad K, Maes M. Tangwongchai S, et al. Mol Neurobiol. 2018 Aug;55(8):6449-6462. doi: 10.1007/s12035-017-0848-0. Epub 2018 Jan 6. Mol Neurobiol. 2018. PMID: 29307083

6

The impact of apolipoprotein E4 on cause of death in Alzheimer's disease.

Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ. Olichney JM, et al. Neurology. 1997 Jul;49(1):76-81. doi: 10.1212/wnl.49.1.76. Neurology. 1997. PMID: 9222173

7

Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.

Landén M, Hesse C, Fredman P, Regland B, Wallin A, Blennow K. Landén M, et al. Dementia. 1996 Sep-Oct;7(5):273-8. doi: 10.1159/000106892. Dementia. 1996. PMID: 8872419

8

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.

Lasser RA, Dukoff R, Levy J, Levin R, Lehtimäki T, Seubert P, Sunderland T. Lasser RA, et al. Int J Geriatr Psychiatry. 1998 Nov;13(11):767-74. doi: 10.1002/(sici)1099-1166(1998110)13:11<767::aid-gps866>3.0.co;2-f. Int J Geriatr Psychiatry. 1998. PMID: 9850873

9

Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.

Mulder M, Ravid R, Swaab DF, de Kloet ER, Haasdijk ED, Julk J, van der Boom JJ, Havekes LM. Mulder M, et al. Alzheimer Dis Assoc Disord. 1998 Sep;12(3):198-203. doi: 10.1097/00002093-199809000-00012. Alzheimer Dis Assoc Disord. 1998. PMID: 9772023

10

Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.

Roses AD, Saunders AM, Corder EH, Pericak-Vance MA, Han SH, Einstein G, Hulette C, Schmechel DE, Holsti M, Huang D, et al. Roses AD, et al. Arzneimittelforschung. 1995 Mar;45(3A):413-7. Arzneimittelforschung. 1995. PMID: 7763336 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

401 results

Results by year